Thursday 23rd August 2018
|Text too small?|
Fisher & Paykel Healthcare Corp has raised its full-year earnings forecast by about $5 million on the back of strong sales growth and the weaker New Zealand dollar.
The firm sells hospital equipment and personal sleep apnoea products in about 120 countries and gets only about 1 per cent of its sales in New Zealand.
Chief executive Lewis Gradon said the recent weakening of the kiwi dollar was a major driver of the earnings upgrade. The kiwi recently traded at 66.75 US cents, and hs dropped about 6 percent so far this year.
At current exchange rates, operating revenue for the six months ending Sept. 30 of $510 million should deliver a net profit of about $95 million. Assuming an exchange rate of 67 US cents for the rest of the year, those measures would rise to $1.07 billion and $215 million respectively for the year ended March 2019, the company told shareholders today.
The firm’s shares rose 6 cents to $15.30 on the NZX, taking their gain this year to almost 9 per cent.
F&P Healthcare increased net profit by 12 percent to $190 million in the March year. Operating revenue climbed 10 percent to $980 million.
In May the firm had forecast current year earnings of $210 million, assuming an exchange rate of 69.50 US cents and operating revenue of $1.05 billion.
No comments yet
NZ dollar edges higher, awaiting further impetus
Productivity Commission appointments bolster labour, health, environment credentials
Keytone Dairy to buy Australian Omniblend processor for A$22.4M
"Very real" chance monetary policy will run out of ammo - ANZ
NZ economy probably grew 0.6% in 1Q but more rate cuts still expected
Local travellers boost guest nights in April on Easter, Anzac holidays
Hisco's departure from ANZ becomes permanent amid personal expenses concerns
NZ services sector activity picks up in May but still tepid
Contact's Barnes to depart
17th June 2019 Morning Report